Showing results (51-60 of 172) with videos related to

Sort By:
Pageof 18
The Journal of Biological Chemistry|January 5, 2002
Dephosphorylation of Ser-259 regulates Raf-1 membrane associationMarkus Kubicek, Margit Pacher, Dietmar Abraham, et al.
Clinical Drug Investigation|December 14, 2006
Long-term safety of intravenous ibandronic acid for up to 4 years in metastatic breast cancer: an open-label trialMartin Pecherstorfer, Saul Rivkin, Jean-Jacques Body, et al.
Lancet (London, England)|June 23, 2009
Multiple myelomaMarc S Raab, Klaus Podar, Iris Breitkreutz, et al.
Oncoimmunology|September 14, 2020
Efficacy and safety of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer (NSCLC): a systematic literature reviewGernot Wagner, Hannah Karolina Stollenwerk, Irma Klerings, et al.
Cancer Research|October 16, 2003
Blockade of Hsp27 overcomes Bortezomib/proteasome inhibitor PS-341 resistance in lymphoma cellsDharminder Chauhan, Guilan Li, Reshma Shringarpure, et al.
Expert Opinion on Emerging Drugs|March 3, 2009
Emerging therapies for multiple myelomaKlaus Podar, Yu-Tzu Tai, Teru Hideshima, et al.
Leukemia|May 19, 2021
JunB is a key regulator of multiple myeloma bone marrow angiogenesisFengjuan Fan, Stefano Malvestiti, Sonia Vallet, et al.
Blood|February 7, 2002
CD40 activation induces p53-dependent vascular endothelial growth factor secretion in human multiple myeloma cellsYu-Tzu Tai, Klaus Podar, Deepak Gupta, et al.
EMBO Molecular Medicine|March 25, 2025
PARP7 as a new target for activating anti-tumor immunity in cancerKaterina Popova, Johannes Benedum, Magdalena Engl, et al.
BMC Nuclear Medicine|December 13, 2003
Comparison of Technetium-99m-MIBI imaging with MRI for detection of spine involvement in patients with multiple myelomaSiroos Mirzaei, Martin Filipits, Andrea Keck, et al.
Pageof 18